The Molecular, Genetic, and Cellular Targets of Cancer Training Program (TCTP; formerly the Cancer Biology Training Grant) at the University of Minnesota Masonic Cancer Center (MCC) combines rigorous training in laboratory-based cancer research with interdisciplinary and translational perspectives that prepares TCTP trainees for independent research careers focused on discovery of the mechanisms of cancer development and progression. Our trainees who do not choose an academic path are highly competitive for leadership positions in a variety of science-related careers. Now in its 44th year of NCI support, the TCTP supports 4 predoctoral and 5 postdoctoral trainees. The 36 preceptors provide research training in three interrelated areas of molecular, genetic, and cellular cancer research that represent particular strengths at the MCC: molecular targets & cancer cell signaling, cancer genetics/epigenetics & DNA damage/repair, and cellular targets & cancer immunology/immunotherapy. The Program consists of intensive one-on-one research mentoring, didactic training in cancer biology and basic and translational cancer research, and regular meetings where trainees develop critical presentation skills, obtain feedback, and establish new research collaborations. Trainees also participate in networking opportunities with prominent external cancer research scientists, and take part in career development activities. Historically, participation of the TCTP Director and Steering Committee members in key leadership positions associated with biomedical research and technology, graduate education, career development, mentoring, and trainee recruitment at the University of Minnesota, have enhanced the TCTP applicant pool and improved the career outcomes of trainees. These efforts have also enhanced our success at recruiting individuals from under-represented groups. New initiatives during the next funding period include a recurring financial commitment from the Medical School and the MCC to support a postdoctoral fellow (salary and benefits), expanding our training capability to 6 postdoctoral trainees. In addition, we will implement short training modules focused on essential skill sets requested by our postdoctoral trainees, including cancer bioinformatics/omics, emerging technologies and ?hot topics? in cancer research, as well as new workshops focused on navigating career transitions. Finally, we have recently partnered with the University of Wisconsin Training in Cancer Biology Training Grant for program-specific retreats. These regional gatherings, designed to enhance trainee networking and regional exposure, will include scientific content as well as career development and mentoring activities designed to meet the specific needs of pre- vs. postdoctoral trainees. These improvements will ensure a robust future of the highest quality training in the molecular, genetic, and cellular mechanisms of cancer at the University of Minnesota. The TCTP is central to the MCC?s mission of educating and training the next generation of scientists and leaders pursuing solutions to the problem of cancer.

Public Health Relevance

The goal of this training program at the University of Minnesota Masonic Cancer Center is to train a diverse group of highly qualified individuals to become future scientific leaders working in basic and translational laboratory research and/or science-related careers to address fundamental problems in cancer biology. A strong scientific work force and the new knowledge they gain will translate to better cancer outcomes.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Institutional National Research Service Award (T32)
Project #
2T32CA009138-46
Application #
10023775
Study Section
Subcommittee I - Transistion to Independence (NCI)
Program Officer
Schmidt, Michael K
Project Start
1980-07-01
Project End
2025-07-31
Budget Start
2020-08-01
Budget End
2021-07-31
Support Year
46
Fiscal Year
2020
Total Cost
Indirect Cost
Name
University of Minnesota Twin Cities
Department
Internal Medicine/Medicine
Type
Schools of Medicine
DUNS #
555917996
City
Minneapolis
State
MN
Country
United States
Zip Code
55455
Jarvis, Matthew C; Ebrahimi, Diako; Temiz, Nuri A et al. (2018) Mutation Signatures Including APOBEC in Cancer Cell Lines. JNCI Cancer Spectr 2:
Wu, Yongxia; Schutt, Steven; Paz, Katelyn et al. (2018) MicroRNA-17-92 is required for T-cell and B-cell pathogenicity in chronic graft-versus-host disease in mice. Blood 131:1974-1986
Marholz, Laura J; Zeringo, Nicholas A; Lou, Hua Jane et al. (2018) In Silico Design and in Vitro Characterization of Universal Tyrosine Kinase Peptide Substrates. Biochemistry 57:1847-1851
Gartlan, Kate H; Bommiasamy, Hemamalini; Paz, Katelyn et al. (2018) A critical role for donor-derived IL-22 in cutaneous chronic GVHD. Am J Transplant 18:810-820
Salzwedel, Amanda O; Han, Joohee; LaRocca, Christopher J et al. (2018) Combination of interferon-expressing oncolytic adenovirus with chemotherapy and radiation is highly synergistic in hamster model of pancreatic cancer. Oncotarget 9:18041-18052
Murphy, Katherine A; James, Britnie R; Sjaastad, Frances V et al. (2018) Cutting Edge: Elevated Leptin during Diet-Induced Obesity Reduces the Efficacy of Tumor Immunotherapy. J Immunol 201:1837-1841
Yang, Rendong; Van Etten, Jamie L; Dehm, Scott M (2018) Indel detection from DNA and RNA sequencing data with transIndel. BMC Genomics 19:270
Bohn, Jennifer A; Van Etten, Jamie L; Schagat, Trista L et al. (2018) Identification of diverse target RNAs that are functionally regulated by human Pumilio proteins. Nucleic Acids Res 46:362-386
Du, Jing; Flynn, Ryan; Paz, Katelyn et al. (2018) Murine chronic graft-versus-host disease proteome profiling discovers CCL15 as a novel biomarker in patients. Blood 131:1743-1754
Regan Anderson, Tarah M; Ma, Shihong; Perez Kerkvliet, Carlos et al. (2018) Taxol Induces Brk-dependent Prosurvival Phenotypes in TNBC Cells through an AhR/GR/HIF-driven Signaling Axis. Mol Cancer Res 16:1761-1772

Showing the most recent 10 out of 270 publications